Efficacy and safety of rucaparib treatment in patients with BRCA-mutated, relapsed ovarian cancer: final results from Study 10.
Rebecca S KristeleitYvette DrewAmit M OzaSusan M DomchekSusana BanerjeeRosalind M GlasspoolJudith BalmañaLee-May ChenManish R PatelHoward A BurrisTamar SafraJennifer BorrowKevin K LinSandra GobleLara MaloneyRonnie Shapira-FrommerPublished in: British journal of cancer (2022)
NCT01482715.